Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.751,82
-0,07%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Corbus Pharmaceuticals Holdings Inc (CRBP) Corbus Pharmaceuticals Holdings Inc (CRBP) Notizie

CRBP

Corbus Pharmaceuticals (CRBP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CRBP
DataOraFonteTitoloSimboloCompagnia
09/05/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
08/05/202422:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/05/202422:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/02/202423:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/02/202423:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202422:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202422:41Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/02/202423:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
31/01/202415:16Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/01/202413:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/06/202312:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
13/06/202322:59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/06/202322:54Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/06/202312:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
22/05/202322:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
19/05/202315:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/05/202323:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/202322:32Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/202322:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
10/03/202322:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/03/202322:30Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/03/202316:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
15/02/202312:07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/11/202223:51Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/11/202212:25TipRanksCorbus Pharmaceuticals (CRBP) Gets a Buy from H.C. WainwrightNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/10/202214:05PR Newswire (US)Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/10/202223:09Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
26/09/202214:05PR Newswire (US)Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of DirectorsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
22/09/202214:00PR Newswire (US)Corbus Presents First Pre-Clinical Data for CRB-913 at the European Association for the Study of Diabetes 2022 Annual ConferenceNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/09/202213:00PR Newswire (US)Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CRBP

La tua Cronologia

NYSE
NCR
NCR
COIN
CSTLUSD
BIT
P15BV5
BNP Paribas Issuance
EU
Q986S
Q986S
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network